Drug · CHEMBL1069
Trials451
Trials whose record names the drug by a name ChEMBL states, posted results first, then the largest. Open Targets read each trial's text to find its drugs. 4 more rest on that reading alone and are shown because the trials' posted result groups or NLM's indexing of their papers name the drug. 43 more that Open Targets linked to it are not shown, since the release's checks do not confirm them.
1 to 20 of 451
Download this page as JSON| Trial | Title | Phase | Participants | Results first posted | Named as | Linked by | Source |
|---|---|---|---|---|---|---|---|
| NCT00097786 | Long-term Study of Nateglinide+Valsartan to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular Complications | Phase 3 | 9,306 | 2011-05-24 | valsartan | Its name | ClinicalTrials.gov |
| NCT01035255 | This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure | Phase 3 | 8,442 | 2015-09-07 | sacubitril-valsartan | A combination that names it | ClinicalTrials.gov |
| NCT02924727 | Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI | Phase 3 | 5,669 | 2023-06-22 | valsartan | Its name | ClinicalTrials.gov |
| NCT01920711 | Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction | Phase 3 | 4,822 | 2020-09-29 | sacubitril/valsartan, valsartan | Its name | ClinicalTrials.gov |
| NCT00149227 | Add-on Effects of Valsartan on Morbi- Mortality (KYOTO HEART Study) | Phase 4 | 3,031 | 2012-12-12 | valsartan | Its name | ClinicalTrials.gov |
| NCT03066804 | A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients | Phase 3 | 2,572 | 2021-02-08 | sacubitril/valsartan | A combination that names it | ClinicalTrials.gov |
| NCT00902304 | Valsartan Intensified Primary Care Reduction of Blood Pressure Study | Phase 4 | 2,337 | 2012-08-30 | valsartan | Its name | ClinicalTrials.gov |
| NCT00425373 | Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential Hypertension | Phase 2/3 | 1,474 | 2011-02-04 | valsartan | Its name | ClinicalTrials.gov |
| NCT00549770 | Efficacy and Safety of LCZ696A in Patients With Essential Hypertension | Phase 2 | 1,334 | 2015-08-10 | valsartan | Its name | ClinicalTrials.gov |
| NCT00696436 | An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension. | Phase 3 | 1,291 | 2011-04-19 | valsartan | Its name | ClinicalTrials.gov |
| NCT00437645 | Efficacy and Safety of Valsartan/Amlodipine Compared to Amlodipine in Patients With Essential Hypertension | Phase 3 | 1,183 | 2011-02-14 | valsartan | Its name | ClinicalTrials.gov |
| NCT01599104 | Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Japanese Patients With Essential Hypertension | Phase 3 | 1,161 | 2015-08-06 | sacubitril/valsartan | A combination that names it | ClinicalTrials.gov |
| NCT00927394 | Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes Mellitus | Phase 4 | 1,143 | 2012-10-31 | valsartan | Its name | ClinicalTrials.gov |
| NCT00413413 | Efficacy/Safety of Valsartan Plus Amlodipine and Valsartan Alone in Patients With Hypertension | Phase 3 | 1,134 | 2009-09-14 | valsartan | Its name | ClinicalTrials.gov |
| NCT05056727 | A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia | Phase 3 | 1,112 | 2026-01-08 | valsartan | Its name | ClinicalTrials.gov |
| NCT00409578 | Efficacy and Safety of Aliskiren and Valsartan Versus Placebo in Patients Stabilized Following an Acute Coronary Syndrome | Phase 2 | 1,101 | 2011-02-02 | valsartan | Its name | ClinicalTrials.gov |
| NCT02661217 | Comparison of Pre- and Post-discharge Initiation of LCZ696 Therapy in HFrEF Patients After an Acute Decompensation Event | Phase 4 | 1,002 | 2021-04-26 | sacubitril/valsartan | A combination that names it | ClinicalTrials.gov |
| NCT00591578 | Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential Hypertension | Phase 3 | 984 | 2011-04-19 | valsartan | Its name | ClinicalTrials.gov |
| NCT01368536 | Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes | Phase 4 | 975 | 2013-03-19 | valturna | Open Targets' reading, confirmed by the trial's result groups | ClinicalTrials.gov |
| NCT00699192 | Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension | Phase 3 | 965 | 2011-06-06 | valsartan | Its name | ClinicalTrials.gov |
pipelines-2026-09-18-0.3.1
Sources 7
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ConductCognition's list of its testsOur own data
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ConductCognition's list of its testsOur own data: ConductCognition's list of its tests, https://conductcognition.com
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/drugs/v1/CHEMBL1069/trials